Researcher.Life Logo

Endokrynologia Polska : Impact Factor & More

eISSN: 2299-8306pISSN: 0423-104X
JournalOpen Access

Key Metrics

CiteScore
2.5
Impact Factor
< 5
SJR
Q3Medicine (all)
SNIP
0.62
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Endokrynologia Polska

Endokrynologia Polska Journal Specifications

Overview
Publisher VIA MEDICA
Language English,Polish
Frequency Bi-monthly
Article Processing ChargesEUR 500
Publication Time20
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageEnglish,Polish
Society/Institute/SponsorPolish Society of Endocrinology
FrequencyBi-monthly
Publication Start Year1949
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 20
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Endokrynologia Polska ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Endokrynologia Polska

Clinical significance of miR-506-5p in type 2 diabetes mellitus and its regulatory effect on pancreatic β-cell proliferation.
  • 1 Jul 2026
  • Endokrynologia Polska
The impact of cytopathologist-performed rapid on-site evaluation on the diagnostic adequacy of thyroid fine-needle aspiration.
  • 29 Jun 2026
  • Endokrynologia Polska
Serum adipocytokine levels in patients with renal cell carcinoma.
  • 29 Jun 2026
  • Endokrynologia Polska
The value of retinal microvascular OCTA parameters for early detection of diabetic kidney disease in patients with non-proliferative diabetic retinopathy.
  • 25 Jun 2026
  • Endokrynologia Polska
MiR-4260 serves as a prognostic biomarker and suppresses thyroid cancer progression.
  • 13 Apr 2026
  • Endokrynologia Polska
High-intensity interval training identifies lipocalin 2 as a potential therapeutic target for hypothalamic neuroprotection in obesity.
  • 1 Jan 2026
  • Endokrynologia Polska
Clinical significance of miR-506-5p in type 2 diabetes mellitus and its regulatory effect on pancreatic β-cell proliferation.
  • 1 Jul 2026
  • Endokrynologia Polska
The impact of cytopathologist-performed rapid on-site evaluation on the diagnostic adequacy of thyroid fine-needle aspiration.
  • 29 Jun 2026
  • Endokrynologia Polska
Serum adipocytokine levels in patients with renal cell carcinoma.
  • 29 Jun 2026
  • Endokrynologia Polska
The value of retinal microvascular OCTA parameters for early detection of diabetic kidney disease in patients with non-proliferative diabetic retinopathy.
  • 25 Jun 2026
  • Endokrynologia Polska
MiR-4260 serves as a prognostic biomarker and suppresses thyroid cancer progression.
  • 13 Apr 2026
  • Endokrynologia Polska
High-intensity interval training identifies lipocalin 2 as a potential therapeutic target for hypothalamic neuroprotection in obesity.
  • 1 Jan 2026
  • Endokrynologia Polska

FAQs on Endokrynologia Polska